NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
Back to search
Official data from USPTO
ACCELERATING THERAPEUTIC DISCOVERY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACCELERATING THERAPEUTIC DISCOVERY
ST13
US500000097606814Class
16, 35, 36
Filing
97606814
Registration
7424706
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
06/25/2024
Trademark type
Word
Nice classes
16, 35, 36
Filing date
09/26/2022
Registration date
06/25/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
06/25/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/04/2010
First use in commerce
05/04/2010
Drawing code
4
Owner type
54
Owner location
CORAL GABLES, FL
Examiner
GADSON, SHARI
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ALPHA-1 FOUNDATION, INC
Alpha-1 Foundation, Inc.
Representatives
Kelly L. Williams QUARLES & BRADY LLP
Technical classification
Nice Classes
Class 16Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed educational materials and promotional materials in the nature of informational flyers in the field of promoting public awareness of the need to increase researchimprove health and worldwide detection and find a cure for Alpha-1-Antitrypsin Deficiency
Class 35
Promoting public awareness of the need to increase researchimprove health and worldwide detection and find a cure for Alpha-1-Antitrypsin Deficiency
Class 36
Providing philanthropic services concerning monetary donations and charitable funding services for providing funding and investment capital to pharmaceutical and biotech companies to advance academic research and the development of new drugs and devices to increase researchimprove health and worldwide detection and find a cure for Alpha-1-Antitrypsin Deficiency
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2024
ALIE
ASSIGNED TO LIE
03/04/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/11/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/11/2023
GNRT
NON-FINAL ACTION E-MAILED
07/11/2023
CNRT
NON-FINAL ACTION WRITTEN
07/11/2023
DOCK
ASSIGNED TO EXAMINER
07/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/30/2022
NWAP
NEW APPLICATION ENTERED
09/29/2022
Continuous trademark protection
Get notified about every new filing that threatens ACCELERATING THERAPEUTIC DISCOVERY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.